Atlantis Formulations Franchise
Brand Information Snapshot
| Brand Name | Atlantis Formulations |
|---|---|
| Industry Category | Pharmaceutical & Healthcare |
| Business Segment | Cardiac and Diabetic Medicines (PCD Pharma Franchise) |
| Founded Year | 2016 |
| Franchise Started Year | 2016 |
| Headquarters | Not specified |
| Number of Franchise Outlets | 1 to 10 |
1. What is Atlantis Formulations?
Atlantis Formulations is a franchise-based pharmaceutical company operating in the healthcare sector, offering cardiac and diabetic medicines through a PCD (Propaganda-Cum-Distribution) franchise model.
The business focuses on the distribution of prescription medicines such as tablets, capsules, and injections. It serves healthcare providers including doctors, clinics, hospitals, and medical retailers.
2. How the Business Works
The business operates as a distribution-driven pharmaceutical model.
Franchise partners are assigned a specific territory where they promote and distribute medicines to healthcare professionals and retailers. The model is based on building relationships with doctors and pharmacies to generate consistent product demand.
Operational Workflow
- Product allocation and territory assignment
- Promotion of medicines to doctors and clinics
- Order collection from pharmacies or healthcare providers
- Supply and distribution of medicines
- Follow-up and repeat order generation
Revenue is generated through margins on medicine sales within the assigned territory.
3. Products or Services Offered
Franchise partners distribute a range of pharmaceutical products.
Core Product Categories
Cardiac Medicines
- Antihypertensive drugs
- Cholesterol management medications
- Blood thinners and related formulations
Diabetic Medicines
- Oral anti-diabetic drugs
- Insulin and related treatments
- Blood sugar control medications
Dosage Formats
- Tablets
- Capsules
- Injectable medicines
The portfolio includes a broad selection of products designed for chronic disease management.
4. How the Franchise Model Works
The franchise model follows a PCD pharma distribution structure.
Role of the Franchise Partner
- Promote products to doctors and healthcare providers
- Manage distribution within a defined territory
- Build relationships with pharmacies and clinics
- Handle order processing and supply coordination
- Manage local sales and marketing activities
Franchisor Support Structure
- Product portfolio and supply
- Marketing and promotional materials
- Exclusive distribution rights in assigned areas
- Ongoing business and sales support
The model enables franchisees to operate as regional distributors without manufacturing responsibilities.
5. Franchise Cost and Investment Overview
The investment requirement is relatively low compared to manufacturing-based pharmaceutical businesses.
| Estimated Investment | INR 50,000 – 2 Lakh |
|---|---|
| Royalty Fee | 10% |
Cost Components
- Initial stock purchase
- Marketing and promotional materials
- Distribution and logistics setup
- Working capital
This structure supports entry into the pharmaceutical distribution business with limited capital.
6. Space and Infrastructure Requirements
The business requires a small operational setup.
Space Requirement: 200 – 500 sq. ft.
Infrastructure Needs
- Storage space for medicines
- Basic office setup
- Inventory management system
Staffing Requirements
- Sales representative or owner-operator
- Support staff for logistics (optional)
The model can be operated with minimal infrastructure.
7. Training and Franchise Support
Franchise partners receive support related to product promotion and business operations.
Support Includes
- Product knowledge and training
- Marketing and promotional support
- Business development guidance
- Ongoing coordination for supply and sales
These systems help franchisees build and manage their distribution network.
8. Revenue Model and ROI Factors
Revenue is generated through pharmaceutical product sales.
Revenue Streams
- Margins on medicine distribution
- Repeat orders from healthcare providers
Business Dynamics
- Demand driven by chronic disease treatment needs
- Recurring demand due to ongoing medication usage
- Relationship-driven sales model
Estimated Payback Period: 1 to 2 years
Profitability depends on territory coverage, product demand, and sales execution.
9. Brand History and Expansion
The company was established in 2016 and began its franchise operations in the same year.
It operates within the pharmaceutical distribution segment with a limited number of franchise outlets ranging between 1 and 10.
The expansion approach focuses on assigning distribution territories to franchise partners across different regions.
10. Key Advantages of the Franchise
- Entry into the pharmaceutical distribution sector
- Focus on chronic disease segments with recurring demand
- Low initial investment requirement
- Territory-based distribution model
- Multiple product categories within a single portfolio
- Marketing and promotional support provided
Franchise Investment Snapshot
| Estimated Investment | INR 50,000 – 2 Lakh |
|---|---|
| Franchise Fee | Not specified |
| Royalty Fee | 10% |
| Space Requirement | 200 – 500 sq. ft. |
| Payback Period | 1 – 2 Years |
| Number of Outlets | 1 to 10 |
Disclaimer: All scores, rankings, and estimates on ForeFind are independently produced editorial assessments using publicly available data and validated brand-submitted information. They are not verified facts, financial advice, or investment recommendations. Full Disclaimer.
